Plus Therapeutics Inc Cash Flow Quality Index
Latest as of June 2025:
-1.13x
Plus Therapeutics Inc cash flow quality index. Plus Therapeutics Inc (PSTV) has a Cash Flow Quality Index of -1.13x as of June 2025. Operating cash flow of $-5.80 Million is below net income of $5.15 Million, suggesting accrual-heavy earnings not yet converted to cash. See Plus Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-1.13x
Operating CF / Net Income
Operating Cash Flow
$-5.80 Million
USD
Net Income
$5.15 Million
USD
Data as of
Jun 2025
Most recent filing
Plus Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Plus Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Plus Therapeutics Inc. For the full cash flow conversion analysis, see Plus Therapeutics Inc cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.